Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
226-240 of 350
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Project Oncology®Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
On the Frontlines of Metastatic Breast CancerOptimizing Quality of Life in HER2+ Metastatic Breast Cancer
Megan Kruse, MD
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Living RheumRecognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Laura Cappelli, MD, MHS,MS
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Clinician's RoundtableProstate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Ihtisham Ahmad
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Project Oncology®Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Colorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
Clinician's RoundtableColorectal Cancer Screening: Evaluating the Cost-Effectiveness of Noninvasive Options
Brian P. McDonough, MD, FAAFP
Carolyn Rutter, PhD
Gloria Coronado, PhD
- advertisement
Cost Considerations for Colorectal Cancer Screening: Examining the Data
Clinician's RoundtableCost Considerations for Colorectal Cancer Screening: Examining the Data
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
On the Frontlines of Metastatic Breast CancerBalancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
Paolo Tarantino, MD
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
On the Frontlines of Metastatic Breast CancerNavigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
Paolo Tarantino, MD
Addressing Barriers to Colorectal Cancer Screening in Rural Populations
Clinician's RoundtableAddressing Barriers to Colorectal Cancer Screening in Rural Populations
Peter Buch, MD, FACG, AGAF, FACP
Michael Dougherty, MD
Weighing the Environmental Impact of Colorectal Cancer Screening Methods
Clinician's RoundtableWeighing the Environmental Impact of Colorectal Cancer Screening Methods
Peter Buch, MD, FACG, AGAF, FACP
A. Mark Fendrick, MD
Reducing Prostate Cancer Cell Production: The Role of Bipolar Androgen Therapy
On the Frontlines of Prostate CancerReducing Prostate Cancer Cell Production: The Role of Bipolar Androgen Therapy
Mohit Khera, M.D., M.B.A., M.P.H.
- advertisement
Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
Project Oncology®Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
Reevaluating Testosterone: A Paradigm Shift in Prostate Cancer Treatment
On the Frontlines of Prostate CancerReevaluating Testosterone: A Paradigm Shift in Prostate Cancer Treatment
Mohit Khera, M.D., M.B.A., M.P.H.
Prostate Cancer Care: Testosterone Therapy’s Impact on Biochemical Recurrence
On the Frontlines of Prostate CancerProstate Cancer Care: Testosterone Therapy’s Impact on Biochemical Recurrence
Mohit Khera, M.D., M.B.A., M.P.H.
